PhosphataseWip1 negatively regulates neutrophil development through p38 MAPK-STAT1

Blood

Volumn 121, Issue 3, 2013, Pages 519-529

  Liu, Guangwei ^a,b   Hu, Xuelian ^a   Sun, Bo ^a   Yang, Tao ^a   Shi, Jianfeng ^a   Zhang, Lianfeng ^c   Zhao, Yong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b FUDAN UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHATASE; STAT1 PROTEIN; UNCLASSIFIED DRUG; WILD TYPE P53 INDUCED PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2C; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELOID PROGENITOR CELL; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOLOGY; LEUKOCYTE DISORDER; LEUKOPOIESIS; MALE; METABOLISM; MOUSE MUTANT; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; FEMALE; HOMEOSTASIS; LEUKOCYTE DISORDERS; LEUKOPOIESIS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID PROGENITOR CELLS; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASES; RESPIRATORY BURST; STAT1 TRANSCRIPTION FACTOR;

MLCS; MLOWN;

EID: 84872593818     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-05-432674     Document Type: Article

References (41)

1. Metcalf D. Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct? Ann N Y Acad Sci. 1999;872:289-303.
2. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012;30:459-489.
3. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519-531.
4. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535. (Pubitemid 38314426)
5. Demetri GD, Griffin JD. Granulocyte colonystimulating factor and its receptor. Blood. 1991; 78(11):2791-2808.
6. Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33(5):657-670.
7. Fiscella M, Zhang H, Fan S, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A. 1997;94(12): 6048-6053. (Pubitemid 27270633)
8. Le Guezennec X, Bulavin DV. WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci. 2010;35(2):109-114.
9. Salminen A, Kaarniranta K. Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cell Signal. 2011;23(5):747-752.
10. Chew J, Biswas S, Shreeram S, et al. WIP1 phosphatase is a negative regulator of NFkappaB signalling. Nat Cell Biol. 2009;11(5):659-666.
11. Lu X, Nguyen TA, Moon SH, Darlington Y, Sommer M, Donehower LA. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev. 2008;27(2):123-135.
12. Oliva-Trastoy M, Berthonaud V, Chevalier A, et al. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene. 2007;26(10):1449-1458. (Pubitemid 46340814)
13. Bulavin DV, Phillips C, Nannenga B, et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet. 2004;36(4):343-350. (Pubitemid 38437256)
14. Choi J, Nannenga B, Demidov ON, et al. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol Cell Biol. 2002;22(4):1094-1105. (Pubitemid 34094846)
15. Liu G, Burns S, Huang G, et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol. 2009;10(7):769-777.
16. Liu G, Duan K, Ma H, Niu Z, Peng J, Zhao Y. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+)Foxp3(+) Treg cells. Immunol Cell Biol. 2011;89(8):827-835.
17. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91(5):661-672. (Pubitemid 27513657)
18. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-197. (Pubitemid 30154488)
19. Miller CL, Lai B. Human and mouse hematopoietic colony-forming cell assays. Methods Mol Biol. 2005;290:71-89.
20. Liu G, Yang K, Burns S, Shrestha S, Chi H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol. 2010;11(11):1047-1056.
21. Rothe G, Emmendorffer A, Oser A, Roesler J, Valet G. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123. J Immunol Methods. 1991; 138(1):133-135.
22. Buser C, Walther P. Freeze-substitution: the addition of water to polar solvents enhances the retention of structure and acts at temperatures around-60 degrees C. J Microsc. 2008;230(2): 268-277. (Pubitemid 351594966)
23. Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005; 201(11):1771-1780. (Pubitemid 41002896)
24. Fiedler K, Sindrilaru A, Terszowski G, et al. Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia. Blood. 2011; 117(4):1329-1339.
25. Basu S, Hodgson G, Katz M, Dunn AR. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood. 2002;100(3):854-861. (Pubitemid 34832610)
26. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125-1129. (Pubitemid 351317447)
27. Kim I, He S, Yilmaz OH, Kiel MJ, Morrison SJ. Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. Blood. 2006;108(2):737-744. (Pubitemid 44061378)
28. Nguyen-Jackson H, Panopoulos AD, Zhang H, Li HS, Watowich SS. STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction. Blood. 2010;115(16):3354-3363.
29. Zhang H, Nguyen-Jackson H, Panopoulos AD, Li HS, Murray PJ, Watowich SS. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood. 2010;116(14):2462-2471.
30. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18(7):4301-4314. (Pubitemid 28287953)
31. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colonystimulating factor. Nat Immunol. 2003;4(10):1029-1036. (Pubitemid 37265925)
32. Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A. 1997;94(24):13187-13192. (Pubitemid 27518497)
33. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996; 88(4):1234-1247. (Pubitemid 26276798)
34. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31(8): 318-324.
35. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010;120(7):2423-2431.
36. Geest CR, Buitenhuis M, Laarhoven AG, et al. p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPalpha on serine 21. Stem Cells. 2009;27(9):2271-2282.
37. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4): 446-451.
38. Takekawa M, Adachi M, Nakahata A, et al. p53- inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 2000; 19(23):6517-6526.
39. Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell. 2007;12(4):342-354. (Pubitemid 47539308)
40. Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E. Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol. 2006;176(8):4818-4825.
41. Pan H, Shively JE. Carcinoembryonic antigenrelated cell adhesion molecule-1 regulates granulopoiesis by inhibition of granulocyte colonystimulating factor receptor. Immunity. 2010;33(4): 620-631.